PS Ratio
59.23
-0.56-0.94%
49 min ago
Summary
- As of February 8, 2025, CYCN price to sales ratio is 59.23, with a fall of -0.56 (-0.94%) during the most recent trading day.
- CYCN PS ratio is now -75.81% below its all-time high of 244.89.
Performance
CYCN PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
CYCN PS Ratio Trends
PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | -0.9% | -0.9% | -0.9% | - |
1 m1 month | +35.9% | +35.9% | +35.9% | - |
3 m3 months | +82.4% | +70.3% | +82.3% | - |
6 m6 months | - | +40.5% | +51.3% | - |
ytdytd | +30.1% | +30.1% | +30.1% | - |
1 y1 year | - | +51.4% | +65.9% | - |
5 y5 years | +138.3% | -94.8% | -89.7% | -95.7% |
CYCN PS Ratio Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -26.0% | 33.99 | +74.3% | |
3 m | 3-month | 80.05 | -26.0% | 19.70 | +200.7% |
6 m | 6-month | 80.05 | -26.0% | 19.70 | +200.7% |
1 y | 1-year | 80.05 | -26.0% | 19.70 | +200.7% |
3 y | 3-year | 89.93 | -34.1% | 5.87 | +909.0% |
5 y | 5-year | 129.02 | -54.1% | 5.87 | +909.0% |
alltime | all time | 244.89 | -75.8% | 5.87 | +909.0% |
Cyclerion Therapeutics PS Ratio History
Date | Value |
---|---|
2025 | 59.23(+30.1%) |
2024 | 45.54(+102.6%) |
Date | Value |
---|---|
2021 | 22.48(-50.5%) |
2020 | 45.38(+172.4%) |
2019 | 16.66 |
FAQ
- What is Cyclerion Therapeutics price to sales ratio?
- What is the all time high PS ratio for Cyclerion Therapeutics?
- What is CYCN price to sales ratio year-to-date change?
What is Cyclerion Therapeutics price to sales ratio?
The current PS ratio of CYCN is 59.23
What is the all time high PS ratio for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high price to sales ratio is 244.89
What is CYCN price to sales ratio year-to-date change?
Cyclerion Therapeutics price to sales ratio has changed by +13.69 (+30.06%) since the beginning of the year